The direct and indirect impact of the COVID-19 pandemic on population-level mortality is of
concern to public health but challenging to quantify. Using data for 2011–2019, we applied …

Intermittent preventive treatment during pregnancy with sulfadoxine–pyrimethamine (IPTp-SP)
has not been evaluated in the Republic of Congo since its implementation in 2006 and …

Malaria in pregnancy remains a serious public health problem in the Republic of Congo despite
the implementation of intermittent preventive treatment with sulfadoxine-pyrimethamine (…

Azoles such as posaconazole (Posa) are highly potent against Trypanosoma cruzi. However,
when tested in chronic Chagas disease patients, a high rate of relapse after Posa …

Since the first published genome sequence of Trypanosoma cruzi in 2005, there have been
tremendous technological advances in genomics, reverse genetics, and assay development …

New assay designs are needed to improve the predictive value of the Trypanosoma cruzi in
vitro tests used as part of the Chagas' disease drug development pipeline. Here, we …

The direct and indirect impact of the COVID-19 pandemic on population-level mortality is of
concern to public health but challenging to quantify. We modelled excess mortality and the …

Chagas' disease is caused by the protozoan parasite Trypanosoma cruzi. Symptoms of the
chronic disease occur decades after infection in about 30% of the infected people. The major …

Background and Aims Autistic children often recall fewer details about witnessed events than
typically developing children (of comparable age and ability), although the information they …

Malaria is an infectious disease of global public health importance. Despite a number of
successful efforts to fight the disease, there are still over 200 million cases and 445,000 deaths …